Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein—a preliminary study on immunogenicity
- 31 December 1992
- Vol. 10 (7) , 439-442
- https://doi.org/10.1016/0264-410x(92)90391-v
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Improved immunogenicity in mice of a recombinant hepatitis B vaccine containing preS1 and preS2 antigens in HBs particlesJournal of Hepatology, 1991
- Hepatitis B vaccination: Half dose recombinant DNA hepatitis B vaccine (B-Hepavac II) is as immunogenic as the full recommended dose in healthy adultsJournal of Gastroenterology and Hepatology, 1991
- Protective potential of hepatitis B virus antigens other than the S gene proteinVaccine, 1990
- Clinical experience with hepatitis B vaccinesAmerican Journal of Infection Control, 1989
- Protective effect of a synthetic peptide comprising the complete pres2 region of the hepatitis b virus surface proteinJournal of Medical Virology, 1989
- Immunological Response to Pre-S Antigens of the Hepatitis B VirusViral Immunology, 1987
- Overview of clinical studies with hepatitis B vaccine made by recombinant DNAJournal of Infection, 1986
- The hepatitis B virusNature, 1985
- HEPATITIS B VACCINATION: HOW LONG DOES PROTECTION LAST?The Lancet, 1984
- Biophysical and biochemical properties of purified preparations of hepatitis B surface antigen (HBS Ag)The Lancet Healthy Longevity, 1975